INTRODUCTION
============

Acute mesenteric ischemia (AMI) comprises 1-2% of acute abdominal emergencies and develops from a sudden decreased perfusion to the intestines ([@B1][@B2][@B3]). Superior mesenteric artery (SMA) embolism is the most common cause of AMI. Although emergent surgical treatment of AMI carries a high morbidity and mortality, the current standard treatment is exploratory laparotomy and surgical removal of the clot ([@B4][@B5]).

Multidetector computerized tomography (MDCT) has facilitated early diagnosis of SMA occlusion and rapid intervention that improves patient prognosis and decreases the incidence of surgical resection of infarcted bowels. For the past 10 years, many reports have described successfully reperfusion of thromboembolic SMA occlusion by several endovascular strategies such as percutaneous aspiration embolectomy, thrombolysis, percutaneous transluminal angioplasty, primary SMA stenting, and a combination of these therapies, sometimes followed by explorative laparotomy for resection of the infarcted bowel segment ([@B1][@B6][@B7][@B8][@B9][@B10][@B11][@B12]). However, the case reports or case series deal with patients treated with diverse technique in different institutions. In this study, we described the technical and clinical outcomes of percutaneous aspiration embolectomy in 9 patients with SMA embolism.

MATERIALS AND METHODS
=====================

Patients
--------

The Institutional Review Board approved this retrospective study, and informed consent was waived. Between January 2010 and December 2013, 9 patients with orgembolic occlusion of the SMA were treated by percutaneous aspiration embolectomy in 2 academic teaching hospitals. The vascular surgeons and interventional radiologists first attempted endovascular treatment, when MDCT scan had no obvious evidence of bowel infarct.

Interventional Procedures
-------------------------

All percutaneous aspiration procedures were performed by 2 experienced interventional radiologists. All procedures were performed under local anesthesia. The procedure was initiated by inserting a 7-Fr sheath (Super Arrow-Flex PSI set, Arrow International, Reading, PA, USA), 45 cm in length, via the common femoral artery. Selective catheterization of the SMA was performed with the 5-Fr Cobra catheter (C1, Cook, Bloomington, IN, USA). SMA angiography was performed to identify the embolism related filling defect, and then a 7-Fr sheath was engaged at the orifice of the SMA. After a 5-Fr catheter (DAV, Cook) of 110 cm in length was inserted within the 7-Fr guiding catheter (Guider Softip XF, Boston Scientific, Natick, MA, USA) of 90 cm in length, the 7-Fr guiding catheter was introduced into the proximal segment of the SMA. A hydrophilic guidewire (Radifocus, Terumo, Tokyo, Japan) was first navigated into the distal segment of the SMA. Then, a 5-Fr catheter was advanced to the distal segment of SMA over the guidewire and a 7-Fr guiding catheter was advanced over the 5-Fr catheter. After removal of the 5-Fr catheter and guidewire, a 50 mL syringe was connected with the 7-Fr guiding catheter. Aspiration of the emboli was applied manually via the 7-Fr guiding catheter. When performing aspiration, the 7-Fr guiding catheter was removed from the 7-Fr sheath. It was necessary to perform percutaneous aspiration several times to completely remove clots from the main trunk of the SMA. A 6-Fr guiding catheter (Guider Softip XF, Boston Scientific) was used to remove the emboli in the branches of the SMA in the same manner.

Thrombolysis was performed using a multiple-sidehole infusion catheter (Multi-Sideport, Cook) or a microcatheter (Microferret, Cook) in 4 patients. Urokinase (Urokinase-GCC; Green Cross, Seoul, Korea) was infused at a rate of approximately 50000-70000 IU per hour to downsize the emboli or resolve residual emboli.

Analysis
--------

The clinical records, MDCT images and digital subtraction angiography were reviewed retrospectively. Complete angiographic success was pronounced when patency of the SMA and sufficient perfusion of the entire bowel were obtained. If angiography demonstrated residual emboli or sluggish flow of SMA, it was defined as a partial angiographic success. The clinical outcome including laparotomy, bowel resection, hospital stay and mortality was evaluated retrospectively.

RESULTS
=======

Patient Characteristics
-----------------------

The patients included 5 men and 4 women, with an age range of 39-88 years (mean age, 67 years). The clinical characteristics of patients were described in [Table 1](#T1){ref-type="table"}. SMA occlusion was initially diagnosed by MDCT in all patients. All patients had no obvious evidence of bowel infarct on MDCT scan. SMA embolism was diagnosed by interventional radiologists and vascular surgeon in consensus considering clinical manifestation and radiologic findings.

Endovascular Intervention
-------------------------

Percutaneous aspiration embolectomy was performed in all 9 patients. It was initially undertaken in 6 patients (No. 2-7), and thrombolysis was initially performed in 3 patients (No. 1, 8, 9). Thrombolysis was initially tried in the early study period, and primary aspiration embolectomy was preferentially performed in the late study period. In 5 patients (No. 2, 3, 5-7) primary percutaneous aspiration embolectomy alone, was applied. In 1 patient (No. 4), primary percutaneous aspiration embolectomy was attempted, but residual emboli were noted in the ileal branches. Thrombolysis was conducted for 10 hours, resulting in complete resolution of the emboli. In 3 patients (No. 1, 8, 9) who received primary thrombolysis, percutaneous aspiration embolectomy was undertaken because the emboli were resistant to urokinase. Aspirated emboli consisted of white and red clots ([Fig. 1](#F1){ref-type="fig"}).

Clinical Outcome
----------------

Complete angiographic success was achieved in 6 patients (No. 1, 2, 4-6, 8) and partial angiographic success was achieved in 3 patients (No. 3, 7, 9). Abdominal symptoms resolved within 6 days in the 6 patients with complete angiographic success. Among the 3 patients with partial angiographic success, 1 patient (No. 3) recovered in 2 days without laparotomy. The other patient (No. 7), whose final angiography showed a slow flow in the jejunal branches, underwent laparotomy because she complained of persistent abdominal pain and rebound tenderness was aggravated, resulting in segmental resection of the infarcted small bowel (1.5 meter). In the remaining patient (No. 9), whose final angiography showed multiple residual emboli and a sluggish flow of SMA, whole bowel necrosis was noted during the laparotomy, resulting in death within 3 days. Details of the outcome were listed in [Table 2](#T2){ref-type="table"}.

Eight patients were discharged without any complication and anticoagulation drugs were prescribed. Two patients (No. 2, 5) had hematochezia after intervention that subsided spontaneously. There was no procedure-related complication such as SMA dissection. Two patients (No. 7, 9) underwent laparotomy and 1 patient (No. 7) received a segmental resection of the small bowel. The 30-day mortality rate was 11% (1 out of 9).

DISCUSSION
==========

A case series of percutaneous SMA aspiration in 15 patients showed 33% (5 of 15 patients) of the 30-day mortality rate ([@B8]). In another case series of 10 patients with acute embolic occlusion of the SMA, 1 patient died at 12 hours and another patient died of short bowel syndrome at 8 months ([@B6]). Recently, Kawasaki et al. ([@B9]) reported 14% (1 of 7 patients) of the 30-day mortality rate and bowel resection in 6 out of 7 patients. In our study, 1 patient needed a segmental bowel resection, and another patient died of sepsis caused by whole bowel necrosis. Although comparison of morbidity and mortality between our study and previous reports has limited value because of small study population, we think that the low morbidity of our study might be explained by the following: 1) patients were diagnosed early by CT scan, 2) patients had relatively mild symptoms and sign, and 3) 3 patients had a partial occlusion of the SMA.

Percutaneous aspiration may be accompanied by the dissection of the SMA and distal embolism. Acosta et al. ([@B6]) reported that SMA dissection developed in 2 out of 10 patients with the use of an 8-Fr or 9-Fr guiding catheter. Kawasaki et al. ([@B9]) reported 1 dissection out of 7 patients with the 6-Fr guiding catheter. If a larger catheter is used, aspiration of the blood clot is facilitated with the concomitant increased risk of SMA dissection. A guiding catheter may scoop out the intima of an artery during its advancement into the distal SMA, resulting in SMA dissection. Hence, it is best to advance the guiding catheter assembled with a seamless dilator to eliminate the gap between the guidewire and the guiding catheter. Since there is no dilator that fits the guiding catheter, a 5-Fr catheter was used as a dilator. There is no gap between the 6-Fr guiding catheter and the 5-Fr catheter, so the 6-Fr guiding catheter was used to remove the emboli in the branches of the SMA. Although there is a small gap between the 7-Fr guiding catheter and the 5-Fr catheter, careful manipulation of the 7-Fr guiding catheter may prevent SMA dissection.

A distal embolism may develop during advancement of the guiding catheter. A blood clot migrated into the distal arteries can be aspirated by using the 6-Fr guiding catheter or the 5-Fr catheter. If the clot is small and collateral flow is intact, no further treatment is needed because bowel ischemia might not be caused by the migrated clot. If collateral flow is not sufficient, additional thrombolysis can be applied to resolve the migrated blood clot.

Thrombolysis is effective on fresh blood clots, but the emboli that are comprised of old blood clots can be resistant to thrombolysis. In contrast, aspiration embolectomy would likely be effective in the removal of the emboli resistant to thrombolysis. Thus, further study comparing thrombolysis and aspiration embolectomy in the SMA embolism is needed.

In this study, we tried endovascular treatment first when CT scan has no obvious evidence of bowel infarct. Rebound tenderness may suggest transmural bowel necrosis and may lead to exploratory laparotomy in some institutions. However, endovascular treatment may make surgical laparotomy unnecessary or may reduce surgical procedure and time if revascularization of the SMA was achieved even in patients with rebound tenderness. The initial treatment modality should be decided by consensus between interventional radiologist and vascular surgeon considering patient\'s symptom and sign, CT findings, laboratory results and their clinical experiences. We could achieve good clinical results in select patients with early diagnosis by CT and relatively mild disease severity.

Six patients with complete angiographic success recovered without further treatment such as bowel resection. Of the 3 patients with partial angiographic success, however, 1 patient died and another patient needed segmental bowel resection. Patients with patent SMA and good flow tended to have better clinical outcome in this study.

Several other devices can be used to remove blood clots in the SMA, including a carotid filter, a mechanical rotational thrombectomy device and a MERIC retrieval device (1[@B10][@B11][@B12]). These devices are also effective in the removal of blood clots, but they may not be available in some institutions and may increase medical costs. Aspiration using a guiding catheter is inexpensive and effective according to several studies including the current study ([@B8][@B9][@B13]).

Transesophageal echocardiography was performed in patient 6 and revealed remnant thrombus in left atrium. In the remaining 6 patients, transthoracic echocardiography was performed and remnant thrombus was not detected in the left atrium. Anticoagulation drugs were prescribed tor all survived patients to prevent re-embolism regardless of findings of echocardiography.

The limitation of our study is the analysis of a small number of enrolled patients that can lead to selection bias and not enough statistical power. Moreover, a comparative study between surgical treatment and endovascular treatment this study was not conducted. Furthermore, overall number of patients with AMI presented at 2 hospitals during the study period is not known.

In conclusion, percutaneous aspiration embolectomy is a useful tool in the recanalization of embolic occlusion of the SMA in select patients.

![88-year-old female presented with abdominal pain and hematochezia.\
**A.** Three-dimensional-volume rendered image of abdominal CT angiograph shows segmental occlusion of proximal superior mesenteric artery (SMA) (arrowheads) with calcified plaque. **B.** Initial angiography shows complete occlusion of SMA (arrowhead) with sluggish flow through distal jejunal branches. Convex meniscus suggests embolic occlusion. **C.** 7-Fr sheath (arrow) was introduced into proximal segment of SMA, and 7-Fr guiding catheter (arrowhead) was advanced into main trunk of SMA. **D.** Angiography after aspiration shows partial recanalized SMA and residual blood clot (arrowheads). **E.** 6-Fr guiding catheter was advanced into distal branch of SMA. **F.** Final angiography shows complete recanalized SMA. **G.** Emboli were removed by guiding catheter. Note fresh thrombotic clots (arrowheads) and old embolic clots (arrows).](kjr-16-736-g001){#F1}

###### Summary of Clinical Features of Nine Patients with SMA Embolism

![](kjr-16-736-i001)

  Patient No.   Age/Sex   Underlying Disease                  Symptom^\*^                                       Tenderness   Rebound Tenderness   Laboratory Test^\*^   Echocardiography^†^                    
  ------------- --------- ----------------------------------- ------------------------------------------------- ------------ -------------------- --------------------- --------------------- ------ --------- ---------------------------
  1             73/M      Af, DM                              Abdominal pain, vomiting, diarrhea                Present      Present              9.5                   15.24                 1.16   Absent    Absent
  2             88/F      Af, CAD, CHF                        Abdominal pain, hematochezia                      Present      Absent               15.5                  2.66                  1.18   NA        
  3             72/M      Af, hyperthyroidism                 Abdominal pain, diarrhea, vomitting, dark stool   Present      Absent               14.2                  17.85                 0.65   Absent    Absent
  4             39/F      MVR, TVR, pacemaker insertion       Abdominal pain                                    Present      Absent               10.2                  0.59                  0.77   Absent    Absent
  5             61/M      CAD, CHF, DM                        Abdominal pain                                    Present      Absent               8.45                  0.18                  1.37   Absent    Severe global hypokinesia
  6             55/M      CAD, DM                             Abdominal pain                                    Present      Present              7.6                   15.2                  0.87   Present   Inferolateral akinesia
  7             66/F      Af, DCMP, MR                        Abdominal pain, vomiting                          Present      Present              16.98                 4.68                  0.94   NA        
  8             71/F      Pacemaker d/t sick sinus syndrome   Abdominal pain                                    Absent       Absent               11.4                  0.16                  1.2    Absent    Absent
  9             78/M      Af, prostate cancer                 Abdominal pain                                    Present      Present              17.6                  0.28                  1.4    Absent    Global hypokinesia of LV

Normal range: WBC count = 4.0-10.0 (× 10^3^/uL), CRP = 0-0.5 (mg/dL), Serum Cr = 0.70-1.40 (mg/dL). ^\*^Symptoms and laboratory tests were based on physical examination and blood samples at admission, ^†^Transthoracic echocardiography was performed in patients 1, 3, 4, 5, 8, and 9. Transesophageal echocardiography was performed in patient 6. Af = atrial fibrillation, CAD = coronary artery disease, CHF = congestive heart failure, CRP = C-reactive protein, DCMP = dilated cardiomyopathy, DM = diabetes mellitus, LA = left atrium, LV = left ventricle, MR = mitral regurgitation, MVR = mitral valve replacement, NA = not applicable, SMA = superior mesenteric artery, TVR = tricuspid valve replacement, WBC = white blood cell

###### Summary of Intervention and Clinical Outcomes of 9 Patients with SMA Embolism

![](kjr-16-736-i002)

  Patient No.                            Findings of CT Scan                   Symptom Onset to Angiography                    Findings of Initial Angiography   Intervention (Aspiration, Thrombolysis)   Findings of Final Angiography   Hospital Stay (d)   Result   Follow-up Period (Months)                                                                                                                                                            
  -------------------------------------- ------------------------------------- ----------------------------------------------- --------------------------------- ----------------------------------------- ------------------------------- ------------------- -------- --------------------------------- ----------------------------------------------------- ---- --------------------------------------------------------------------------------------- --------
  1                                      Yes                                   Mild ileus                                      3 days                            Partial                                   4 cm                            5                   Good     Thrombolysis and aspiration^\*^   No residual emboli, good flow                         10   Abdominal symptom resolved in 1 day                                                     38
  2                                      Yes                                   Scanty ascites                                  18 hours                          Complete                                  6 cm                            3                   Slow     Aspiration                        No residual emboli, good flow                         9    Hematochezia develop after aspiration, but subsided spontaneously                       25
  Mild bowel edema                       Abdominal symptom resolved in 1 day                                                                                                                                                                                                                                                                                                                                                                                 
  3                                      Yes                                   Mild ileus and bowel edema                      36 hours                          Partial                                   5 cm                            8                   Good     Aspiration                        Some residual emboli in jejunal branch, good flow     12   Abdominal symptom resolved in 2 days                                                    32
  4                                      No                                    Multifocal infarcts in both kidney and spleen   4 hours                           Complete                                  10 cm                           7                   Good     Aspiration and thrombolysis^†^    No residual emboli, good flow                         11   Abdominal symptom resolved in 4 days                                                    17
  5                                      Yes                                   Mild ileus                                      4 hours                           Complete                                  1 cm                            0                   Absent   Aspiration                        No residual emboli, good flow                         20   Hematochezia develop after aspiration, but subsided spontaneously                       5
  Abdominal symptom resolved in 6 days                                                                                                                                                                                                                                                                                                                                                                                                                       
  6                                      Yes                                   Mild ileus                                      1 week                            Partial                                   5 cm                            6                   Good     Aspiration                        No residual emboli, good flow                         22   Abdominal symptom resolved in 1 day                                                     12
  7                                      Yes                                   Mild ileus                                      5 hours                           Complete                                  6 cm                            3                   Absent   Aspiration                        No residual emboli, slow flow in jejunal branches     16   Laparotomy and segmental bowel resection was performed 1 day after intervention         3
  Abdominal symptom resolved in 5 days                                                                                                                                                                                                                                                                                                                                                                                                                       
  8                                      No                                    Mild ileus                                      12 hours                          Complete                                  8 cm                            6                   Good     Thrombolysis and aspiration^‡^    No residual emboli, good flow                         8    Abdominal symptom resolved in 1 day                                                     32
  9                                      Yes                                   Mild ileus                                      17 hours                          Complete                                  5 cm                            2                   Slow     Thrombolysis and aspiration^§^    Multiple residual emboli in SMA branches, slow flow   3    Laparotomy was performed 1 day after intervention, and whole bowel necrosis was noted   3 days
  Expired in 3 days                                                                                                                                                                                                                                                                                                                                                                                                                                          

^\*^Thrombolysis using urokinase was performed for 24 hours, but no improvement was noted. Then, aspiration thrombectomy was performed, ^†^Aspiration thrombectomy was performed, but residual thrombus in ileal branch was noted. Then, thrombolysis using urokinase was performed for 10 hours, ^‡^Thrombolysis using urokinase was performed for 8 hours, but abundant residual thrombus was noted. Then, aspiration thrombectomy was performed and small residual thrombus in ileal branch was noted. Then additional thrombolysis using urokinase was performed for 6 hours, ^§^Thrombolysis using urokinase was performed for 9 hours, but abundant residual thrombus was noted. Then, aspiration thrombectomy was performed. SMA = superior mesenteric artery

[^1]: ^\*^Two authors have contributed equally to this work.
